Prospective clinical study onthe value of nuclear matrixprotein (NMP22) as a urinarytumor marker in the diagnosisand follow up of patients withbladder cancer

Study of the role of cytokeratin 19 in diagnosis of cancer bladder

Urinary hyaluronic acid : A marker forbladder cancer detection and evaluation of aggressiveness

Ultrastructural study of peripheral blood mononuclear cells in patients with urinary bladder carcinoma

Evaluation of a new tumour marker in patients with non-small cell lung cancer: CYFRA 21-1

Evaluation of chromogranin A as atumor marker for cancer prostate

Evaluation of neuron specific enolase (NSE),tissue polypeptide specific antigen (TPS) andscatter factor (SF) as diagnostic andprognostic markers of cancer prostate

The value of various prostate cancer tumor markers in early detection, diagnosis, follow up and monitoring of the treatment

Progastrin releasing peptide as a tumor marker for cancer prostate

Detection of self renewal genes NANOG and STAT3 expression in cancer bladder cells